Kevin Warshs Potential Fed Leadership Could Reshape Market Intervention Framework Senators Urged to Avoid Intervening in College Footballs Prosperous Landscape General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Analysts Warn MegaIPOs from SpaceX and OpenAI Could Signal Market Peak Memory Chip Bottleneck Propels Roundhill Memory ETF DRAM to Record 98 Billion AUM in 43 Days Meta Plans 60B65B Capital Spending Drive Fueled by AI Ambitions and Data Center Expansion Maison Solutions Inc MSS Q1 2026 Earnings Significant Earnings Miss Raises Concerns BUD Q1 2026 Earnings EPS Beats Estimates by 815 Yet Shares Slip Marriott Vacations Worldwide VAC Q1 2026 Earnings EPS Miss Weighs on Sentiment but Stock Ticks Higher ETSY Q1 2026 Earnings Earnings Beat Expectations with Strong EPS Surprise Americold Realty Trust COLD Q1 2026 Earnings NarrowerThanExpected Loss Lifts Sentiment EPR Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Response AROW Q1 2026 Earnings EPS Beats Estimates by 176 as Shares Edge Higher Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline LUMN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Restructuring Challenges Persist NI Holdings Q4 2022 Earnings Positive EPS Despite Limited Disclosure Stock Slips NVMI Q1 2026 Earnings EPS Beats Estimates as Semiconductor Metrology Demand Drives Performance Morgan Stanley Lowers Southern Company Target Cites Potential Utility Sector Underperformance Lear Corporation LEA Q1 2026 Earnings Strong EPS Beat Drives Stock Rally Amid Supply Chain Improvements TTI Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement East West Bancorp Inc Q1 2026 Earnings Modest EPS Beat Amid Steady Operations GFS Q1 2026 Earnings Earnings Beat Expectations on EPS Shares Rise Kimball Electronics Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Rise BLCO Q1 2026 Earnings EPS Surpasses Estimates by 365 Stock Declines 14 Saia Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips Slightly ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds